Elevated pressure, a novel cancer therapeutic tool for sensitizing cisplatin-mediated apoptosis in A549

Biochemical and Biophysical Research Communications
Sangnam OhEunil Lee

Abstract

Intensive cancer therapy strategies have thus far focused on sensitizing cancer cells to anticancer drug-mediated apoptosis to overcome drug resistance, and this strategy has led to more effective cancer therapeutics. Cisplatin (cis-diamminedichloroplatinum(II), CDDP) is an effective anticancer drug used to treat many types of cancer, including non-small cell lung carcinoma (NSCLC), and can be used in combination with various chemicals to enhance cancer cell apoptosis. Here, we introduce the use of elevated pressure (EP) in combination with CDDP for cancer treatment and explore the effects of EP on CDDP-mediated apoptosis in NSCLC cells. Our findings demonstrate that preconditioning NSCLC cells with EP sensitizes cells for CDDP-induced apoptosis. Enhanced apoptosis was dependent on p53 and HO-1 expression, and was associated with increased DNA damage and down-regulation of genes involved in nucleotide excision repair. The transcriptional levels of transporter proteins indicated that the mechanism by which EP-induced CDDP sensitization was intracellular drug accumulation. The protein levels of some antioxidants, such as hemeoxygenase-1 (HO-1), glutathione (GSH) and glutathione peroxidase (Gpx), were decreased in A549 cells expos...Continue Reading

References

Mar 1, 1989·The Laryngoscope·T McMillanS Rajaraman
Jul 7, 1995·The Journal of Biological Chemistry·A Sancar
Dec 3, 1999·Biochimica Et Biophysica Acta·D R HipfnerS P Cole
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
Nov 1, 2001·Cell Death and Differentiation·S Benchimol
Dec 26, 2001·Chemical Reviews·E R Jamieson, S J Lippard
Mar 21, 2002·Nature Reviews. Cancer·Adrian L Harris
Dec 5, 2002·Mutation Research·Günter SpeitAndreas Rothfuss
Sep 12, 2003·DNA Repair·Shanthi Adimoolam, James M Ford
Nov 7, 2003·Journal of Vascular Surgery·Chris HealeyAndrew Stanley
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ute Warnecke-EberzPaul M Schneider
Jul 29, 2004·DNA Repair·Oscar Fernandez-CapetilloAndré Nussenzweig
Jan 22, 2005·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Jerry S Vande BergMartin C Robson
Mar 1, 2005·The Journal of Surgical Research·Andrew C StanleyMichael A Ricci
Mar 25, 2005·Nature Reviews. Drug Discovery·Dong Wang, Stephen J Lippard
Nov 15, 2006·World Journal of Surgery·Jurstine Daruwalla, Chris Christophi
Feb 24, 2007·Cancer Metastasis Reviews·Macus Tien KuoToshihisa Ishikawa
Mar 21, 2007·Journal of Cellular Biochemistry·Woo Hyun ParkSung Zoo Kim
Aug 3, 2007·Journal of Drug Targeting·J FangA K Iyer
Sep 8, 2007·Antioxidants & Redox Signaling·Alicja JozkowiczJozef Dulak
Jan 29, 2008·Seminars in Oncology Nursing·Elizabeth S Waxman
Jan 31, 2009·Veterinary and Comparative Oncology·K BarabasC Adin
Jul 14, 2010·Apoptosis : an International Journal on Programmed Cell Death·Sangnam OhEunil Lee

❮ Previous
Next ❯

Citations

Feb 1, 2011·Acta Pharmacologica Sinica·Shuang-shuang WuJian-qing Wu
Dec 23, 2015·Cancer Investigation·Sichuang TanWeilin Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.